Vimarsana
Biggest News Aggregation in the World

Page 10 - Concept Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Concept Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Concept Study Today - Breaking & Trending Today

NASA Reveals Study Plan For 2040 Eco-Airliner | Aviation Week Network - Vimarsana News

NASA Reveals Study Plan For 2040 Eco-Airliner | Aviation Week Network

New NASA green airliner study to go beyond agency’s sustainable X-plane to include technology for broader reduced environmental impacts.

Newcrest Mining Limited - Red Chris Block Cave PFS Confirms Tier 1 Potential - Vimarsana News

Newcrest Mining Limited - Red Chris Block Cave PFS Confirms Tier 1 Potential

Confirms Red Chris potential to become a world class, long life mineEstimated 17% IRR and C$2.3 billion NPV over an initial 31 year mine life1,2,3Projected average 316kozpa gold and 80ktpa copper production

AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology - Vimarsana News

AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology

AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology ABBVie today announced that it will present new data from a total of 41 abstracts covering its portfolio of immunology assets, including RINVOQ ® SKYRIZI ® HUMIRA ® and its pipeline across multiple rheumatic diseases at the EULAR 2021 Virtual Congress of Rheumatology, to be held virtually June 2-5 . Among the data presented will be new three-year and one-year efficacy and safety data for RINVOQ for the treatment … – ABBVie (NYSE: ABBV) today announced tha...

Recce Pharmaceuticals (ASX:RCE) makes first steps towards new trials - Vimarsana News

Recce Pharmaceuticals (ASX:RCE) makes first steps towards new trials

Recce Pharmaceuticals (ASX:RCE) makes first steps towards new trials SubscribeBe the first with the news that moves the market Recce Pharmaceuticals (RCE) has lodged an application to commence human clinical trials for its topical burns treatment, RECCE 327 The ASX-lister announced it had registered for the trial with the Australian and New Zealand Clinical Trial Registry for a phase I/II topical burns study The study is set to test 30 patients over two weeks in a bid to test the efficacy of the drug In a broader context, Recce said the application represents one of the final administration ...

NCM Announces Red Chris Receives Regulatory and Funding Approval - Vimarsana News

NCM Announces Red Chris Receives Regulatory and Funding Approval

NCM Announces Red Chris Receives Regulatory and Funding Approval Newcrest Mining Limited is pleased to announce that it has commenced construction of the box-cut for the exploration decline at its Red Chris mine in British Columbia, following receipt of the necessary regulatory approvals. The Newcrest Board has also approved C$135 million of funding for the construction of the exploration decline and associated infrastructure and permitting costs. These works are expected to … Newcrest Mining Limited (ASX: NCM) (TSX: NCM) (PNGX: NCM) is pleased to announce that it has commenced construction...